Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Rifapentine Capsules

Approval Number

国药准字H20133047

Company河北爱尔海泰制药有限公司

Registration Date

July 28, 2022

Previous Approval Numbers

国药准字H20133047

Drug Information

Generic Name

利福喷丁胶囊

Dosage Form

胶囊剂

Strength

0.15g

Drug Type

化学药品

Registration Date

July 28, 2022

Company Information

Applicant Company

Company Name河北爱尔海泰制药有限公司

Company Address

石家庄高新技术产业开发区泰山街219号

Manufacturing Company

Company Name河北爱尔海泰制药有限公司

Company Address

石家庄高新技术产业开发区泰山街219号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy